BC2-IR700

N/A

Report date: 2022/04/18 13:33:34

Base Information

Drug NameBC2-IR700
Drug Alias NameBC2-IR700BC-2-IR700BC2-IR-700BC-2-IR-700
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Tsukuba
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Tsukuba
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A